A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Bio Techne Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 323,500 shares of TECH stock, worth $22.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
323,500
Holding current value
$22.2 Million
% of portfolio
0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.96 - $82.35 $23 Million - $26.6 Million
323,500 New
323,500 $25.9 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $10.4 Million - $15.4 Million
197,100 Added 125.94%
353,600 $27.3 Million
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $27,008 - $35,768
-400 Reduced 0.25%
156,500 $10.7 Million
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $5.49 Million - $6.4 Million
74,400 Added 90.18%
156,900 $12.8 Million
Q1 2023

May 15, 2023

SELL
$71.62 - $86.62 $1.23 Million - $1.49 Million
-17,200 Reduced 17.25%
82,500 $6.12 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $4.82 Million - $21 Million
59,700 Added 149.25%
99,700 $8.26 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $254,286 - $352,665
-900 Reduced 2.2%
40,000 $11.4 Million
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $32,267 - $44,965
-100 Reduced 0.24%
40,900 $14.2 Million
Q1 2022

May 16, 2022

SELL
$353.85 - $487.79 $318,465 - $439,011
-900 Reduced 2.15%
41,000 $17.8 Million
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $18.6 Million - $22.6 Million
41,900 New
41,900 $20.3 Million
Q4 2017

Feb 14, 2018

SELL
$121.17 - $134.75 $7.27 Million - $8.09 Million
-60,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $6.82 Million - $7.43 Million
60,000
60,000 $7.25 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.7B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.